Span Divergent Ltd
Span Divergent Ltd (524727): company summary
The company's revenue grew 92.3% annually, but net profit remained a loss, widening from ₹1 crore to ₹3 crore.
Span Divergent Ltd (524727) is a micro-cap Healthcare company valued at ₹17 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Span Divergent Ltd last traded at ₹23.15, up 4.99% on the day.
- Recent developments
- 2026-06-30: The company reported a net loss of ₹1 crore in the latest quarter, following a loss of ₹1 crore in the previous quarter. 2026-03-31: The company's revenue was ₹5 crore, with a net loss of ₹1 crore, compared to ₹4 crore revenue and a ₹1 crore loss in the prior quarter.
- Financial performance
- The company's revenue grew 92.3% annually, but net profit remained a loss, widening from ₹1 crore to ₹3 crore. The latest quarter saw revenue fall 4.7% year-on-year while the net loss widened from ₹0 crore to ₹1 crore.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 1.43 times book value.
- Things to watch
- The company's net profit margin worsened to -17.1% from -14.3% in the prior year. The net loss widened from ₹1 crore to ₹3 crore annually. The promoter holding decreased by 15.9% over the last three years.
- Where it stands
- The company's business shows strong revenue growth, but net profit remains a loss, with the latest quarter's loss widening. The promoter holding has decreased over the last three years, and the stock is 43.1% below its 52-week high.
Summarised by DocStoX's model on 2026-09-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.5) and valuation (6.0), but held back by momentum (0.0). Growth looks strong at 7.5, but that is offset by momentum at 0.0 and quality at 0.7. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Revenue compounding 18% a year
- Loss-making — no meaningful P/E
- Loss-making in some of the last 5 years
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Span Divergent Ltd’s valuation
Free deep-dive tools · no sign-up
Span Divergent Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Span Divergent Ltd with peers
Related tools & concepts
Value Span Divergent Ltd with the ratios and calculators DocStoX uses in its analysis.

